There are no validated dosing guidelines for DSIP, and figures that circulate online are not anchored in robust human studies
Depending on which part of the nervous system is affected, symptoms can include numbness, paralysis and vision impairment
The precise timeline based on clinical trial tracking: Weeks 1-3: Mild symptoms beginning, most patients adapting to medication Weeks 4-8: Peak side effect period highest nausea, GI symptoms at their worst Weeks 9-12: Rapid improvement, most GI symptoms resolving Weeks 13-24: Minimal symptoms for most, discontinuation rate drops to under 2% Weeks 25-48: Essentially no side effects for 85%+, focus shifts to weight maintenance According to research published in the New England Journal of Medicine on GLP-1 agonists, this pattern is consistent across the entire class of incretin-based therapies
Glutathione is critical for long-term health and disease prevention, so eating a diet rich in glutathione makes sense
We dont know the timing during the day or the timing of when it is administered in the setting of an injury. As a result, patients often try a variety of doses at various intervals with unclear benefits
